US Edition
Kedrion Raises Awareness Around Plasminogen Deficiency
- On May 5, 2025, Kedrion Biopharma hosted a range of online and face-to-face activities to highlight Plasminogen Deficiency and its impact.
- The campaign followed Plasminogen Deficiency Awareness Day on May 4, aiming to educate the public about this rare genetic disorder and its early diagnosis.
- Global events brought together doctors, patients, and key participants to share powerful experiences about PLGD-1, a rare condition affecting approximately 12,000 individuals around the globe.
- Bob Rossilli, General Manager for Kedrion's Global Business and US operations, emphasized that their team is dedicated to collaborating with healthcare professionals, advocacy organizations, and other partners to raise awareness and support for individuals living with PLGD1.
- The campaign underscored the critical need for awareness and early diagnosis to prevent severe consequences and highlighted Kedrion’s role as the only FDA approved therapy manufacturer.
Insights by Ground AI
Does this summary seem wrong?
87 Articles
87 Articles
All
Left
12
Center
29
Right
4
InsideNoVA.com+86 Reposted by 86 other sources
Kedrion Raises Awareness Around Plasminogen Deficiency
FORT LEE, N.J., May 5, 2025 /PRNewswire/ -- Kedrion Biopharma is raising awareness for Plasminogen Deficiency (PLGD-1) with virtual, digital and in person events throughout the day on May 5. PLGD-1 is a rare genetic disorder affecting approximately 1.6 in…
Coverage Details
Total News Sources87
Leaning Left12Leaning Right4Center29Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 27%
C 64%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
